WheyTech Bionics, a Wellington-based company researching uses for the cheesemaking by-product whey, has partnered with MPI on a two-year project to develop technology that could develop whey permeate into a product with anti-diabetic properties.
WheyTech chief executive Ben Van Rooy spoke to NBR
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).